Federico Gobbi

The Global Prevalence of Strongyloides stercoralis Infection

Dora Buonfrate, Donal Bisanzio, Giovanni Giorli et al. · Pathogens · 2020 · 386 citations · Full text

Parasitic Disease, Strongyloidiasis Burden, Epidemiological Dynamic +25

Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection

Federico Gobbi, Dora Buonfrate, Lucía Moro et al. · Viruses · 2021 · 197 citations · Full text

Naïve Individuals, Immunology, Antibody Response +16

Surveillance and outbreak reports

Sara Atkin, S Anaraki, Philip Gothard et al. · Eurosurveillance · 2009 · 190 citations · Full text

Epidemic Intelligence, Emerging Infectious Diseases, Disease Surveillance +8

Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial

Dora Buonfrate, Joaquín Salas-Coronas, José Muñóz et al. · The Lancet Infectious Diseases · 2019 · 164 citations · Full text

Superiority Trial, Antimicrobial Stewardship, Antibiotics +6

Rapid malaria diagnostic tests <i>vs.</i> clinical management of malaria in rural Burkina Faso: safety and effect on clinical decisions. A randomized trial

Zeno Bisoffi, Sodiomon B. Sirima, Andrea Angheben et al. · Tropical Medicine & International Health · 2009 · 112 citations · Full text